|
|
 |
|
Viewing report
|
|
|
|
Anavex Life Sciences Corp. (AVXL) - Financial and Strategic SWOT Analysis Review
GlobalData, Feb 2012, Pages: 34
Anavex Life Sciences Corp. (AVXL) - Financial and Strategic SWOT Analysis Review
Summary
Anavex Life Sciences Corp.(Anavex) is a development-stage biopharmaceutical company engaged in the discovery and development of drugs for the treatment of neurological diseases and cancer, utilizing its proprietary drug discovery SIGMACEPTOR platform. The company's strong in-house research capabilities helped in developing a portfolio of potential pipeline product candidates, with over 30 novel drug candidates. Anavex group involves new sigma receptor compounds (ligands) in pre-clinical stage that target various therapeutic areas such as Inflammation, Central Nervous System (CNS) and Cancer. The company is headquartered at New Jersey, the US.
Anavex Life Sciences Corp. Key Recent Developments
Oct 12, 2011: Anavex Appoints George Tidmarsh As Executive Director
Aug 12, 2011: Anavex Life Sciences Reports Q3 Fiscal 2011 Results
May 16, 2011: Anavex Life Sciences Reports Q2 Fiscal 2011 Results
Feb 14, 2011: Anavex Life Sciences Reports Q1 Fiscal 2011 Results
Feb 04, 2011: Anavex Appoints Angelos Stergiou As Vice President Of Clinical Development And Medical Affairs
This comprehensive SWOT profile of Anavex Life Sciences Corp. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Key Words
Anavex Life Sciences Corp., SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
Customers who bought this item also bought
Anavex Life Sciences Corp. - Product Pipeline Review - Q2 2011
Anavex Life Sciences Corp. - Product Pipeline Review - Q4 2010
Anavex Life Sciences Corp. - Product Pipeline Review - Q4 2010
Anavex Life Sciences Corp. - Product Pipeline Review - 2012
Life Technologies Corporation (LIFE) - Financial and Strategic SWOT Analysis Review
Kolon Life Science, Inc. (102940) - Financial and Strategic SWOT Analysis Review
Amorfix Life Sciences Ltd. (AMF) - Financial and Strategic SWOT Analysis Review
Synta Pharmaceuticals Corp. (SNTA) - Financial and Strategic SWOT Analysis Review
Actelion Ltd (ATLN) - Financial and Strategic SWOT Analysis Review
Narhex Life Sciences Limited (NLS) - Financial and Strategic SWOT Analysis Review
|
|
|
|
